Norway

Norway

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.01 (0 - 0.03) 2015 Modelled WHO
0.3 (0.30 - 0.40) 2016 Modelled Razavi-Shearer et al, 2018
0.01 (0 - 0.03) 2013 Modelled Schweitzer et al, 2015
0.52 (0.45 - 0.60) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.56 (0.48 - 0.64) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.49 - 0.65) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.51 - 0.67) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.53 - 0.70) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.54 - 0.71) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.55 - 0.72) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.56 - 0.74) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.58 - 0.76) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.58 - 0.77) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.59 - 0.78) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.60 - 0.79) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.62 - 0.81) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.63 - 0.83) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.64 - 0.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.64 - 0.85) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.65 - 0.85) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.65 - 0.86) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.65 - 0.86) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.86) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.66 - 0.87) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.87) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.67 - 0.88) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.68 - 0.89) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.68 - 0.89) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.68 - 0.89) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.68 - 0.90) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.69 - 0.90) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.69 - 0.91) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.69 - 0.92) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.56 (0.48 - 0.64) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.01 (0 - 0.03) 2015 Modelled WHO
0.03 (0.03 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.05 (0.04 - 0.07) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.04 - 0.07) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.08) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.05 - 0.08) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.05 - 0.09) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.06 - 0.11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.08 - 0.14) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.12 - 0.20) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.26 (0.19 - 0.33) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.37 (0.28 - 0.48) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.47 (0.36 - 0.61) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.39 - 0.67) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.39 - 0.67) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.39 - 0.67) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.39 - 0.66) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.38 - 0.65) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.38 - 0.65) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.38 - 0.65) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.51 (0.38 - 0.66) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.38 - 0.66) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.38 - 0.67) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.52 (0.39 - 0.68) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.02 (0.01 - 0.03) 2020 Modelled WHO
Showing out of
Show more
Pregnant women
Download
Value (%) Year Type Source
0.1 (0 - 0.30) 2004 Survey/reported Kristiansen MG et al, 2009
People who inject drugs (PWID)
Download
Value (%) Year Type Source
0.9 2015 Survey/reported EMCDDA
Technical notes

Number of persons living with chronic HBV

National
Download
Value Year Type Source
17,000 (15,000 - 20,000) 2016 Modelled Razavi-Shearer et al, 2018
27,897 (24,023 - 31,859) 2019 Modelled IHME, GBD 2019 (accessed 2020)
28,539 (24,613 - 32,548) 2019 Modelled IHME, GBD 2019 (accessed 2022)
28,272 (24,422 - 32,377) 2018 Modelled IHME, GBD 2019 (accessed 2022)
28,132 (24,343 - 32,230) 2017 Modelled IHME, GBD 2019 (accessed 2022)
29,133 (25,180 - 33,223) 2016 Modelled IHME, GBD 2019 (accessed 2022)
30,108 (26,030 - 34,190) 2015 Modelled IHME, GBD 2019 (accessed 2022)
30,135 (26,106 - 34,241) 2014 Modelled IHME, GBD 2019 (accessed 2022)
30,463 (26,324 - 34,628) 2013 Modelled IHME, GBD 2019 (accessed 2022)
30,874 (26,734 - 35,129) 2012 Modelled IHME, GBD 2019 (accessed 2022)
31,160 (26,974 - 35,481) 2011 Modelled IHME, GBD 2019 (accessed 2022)
31,105 (26,950 - 35,433) 2010 Modelled IHME, GBD 2019 (accessed 2022)
31,024 (26,865 - 35,313) 2009 Modelled IHME, GBD 2019 (accessed 2022)
31,253 (27,051 - 35,568) 2008 Modelled IHME, GBD 2019 (accessed 2022)
31,620 (27,374 - 36,004) 2007 Modelled IHME, GBD 2019 (accessed 2022)
31,954 (27,688 - 36,342) 2006 Modelled IHME, GBD 2019 (accessed 2022)
32,066 (27,824 - 36,443) 2005 Modelled IHME, GBD 2019 (accessed 2022)
32,034 (27,797 - 36,354) 2004 Modelled IHME, GBD 2019 (accessed 2022)
32,045 (27,809 - 36,364) 2003 Modelled IHME, GBD 2019 (accessed 2022)
32,072 (27,834 - 36,393) 2002 Modelled IHME, GBD 2019 (accessed 2022)
32,089 (27,808 - 36,421) 2001 Modelled IHME, GBD 2019 (accessed 2022)
32,064 (27,757 - 36,397) 2000 Modelled IHME, GBD 2019 (accessed 2022)
32,043 (27,768 - 36,365) 1999 Modelled IHME, GBD 2019 (accessed 2022)
32,070 (27,831 - 36,425) 1998 Modelled IHME, GBD 2019 (accessed 2022)
32,109 (27,916 - 36,475) 1997 Modelled IHME, GBD 2019 (accessed 2022)
32,117 (27,944 - 36,496) 1996 Modelled IHME, GBD 2019 (accessed 2022)
32,057 (27,839 - 36,443) 1995 Modelled IHME, GBD 2019 (accessed 2022)
31,991 (27,843 - 36,415) 1994 Modelled IHME, GBD 2019 (accessed 2022)
31,990 (27,770 - 36,450) 1993 Modelled IHME, GBD 2019 (accessed 2022)
32,035 (27,809 - 36,532) 1992 Modelled IHME, GBD 2019 (accessed 2022)
32,100 (27,773 - 36,635) 1991 Modelled IHME, GBD 2019 (accessed 2022)
32,158 (27,691 - 36,823) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
0.96 (0.83 - 1.11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1.29 (1.13 - 1.48) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.11 - 1.44) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.12 - 1.45) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.13 - 1.47) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.13 - 1.47) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1.12 - 1.46) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.3 (1.13 - 1.47) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.14 - 1.49) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.16 - 1.52) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.16 - 1.52) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.16 - 1.51) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.15 - 1.51) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.15 - 1.52) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.15 - 1.51) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.16 - 1.52) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.14 - 1.49) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.32 (1.15 - 1.51) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.35 (1.17 - 1.54) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.19 - 1.56) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.19 - 1.56) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.37 (1.19 - 1.56) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (1.18 - 1.55) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.10 - 1.44) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.05 (0.92 - 1.19) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (1.02 - 1.34) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.88 - 1.14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.01 (0.87 - 1.15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.85 - 1.12) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.84 - 1.11) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.83 - 1.11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
49 2016 Modelled WHO
55 (48 - 63) 1990 Modelled IHME, GBD 2019 (accessed 2022)
54 (47 - 62) 1991 Modelled IHME, GBD 2019 (accessed 2022)
55 (48 - 62) 1992 Modelled IHME, GBD 2019 (accessed 2022)
56 (49 - 63) 1993 Modelled IHME, GBD 2019 (accessed 2022)
56 (49 - 63) 1994 Modelled IHME, GBD 2019 (accessed 2022)
56 (49 - 64) 1995 Modelled IHME, GBD 2019 (accessed 2022)
57 (50 - 65) 1996 Modelled IHME, GBD 2019 (accessed 2022)
57 (50 - 66) 1997 Modelled IHME, GBD 2019 (accessed 2022)
59 (51 - 67) 1998 Modelled IHME, GBD 2019 (accessed 2022)
59 (52 - 67) 1999 Modelled IHME, GBD 2019 (accessed 2022)
60 (52 - 68) 2000 Modelled IHME, GBD 2019 (accessed 2022)
60 (52 - 69) 2002 Modelled IHME, GBD 2019 (accessed 2022)
59 (52 - 68) 2001 Modelled IHME, GBD 2019 (accessed 2022)
60 (52 - 69) 2003 Modelled IHME, GBD 2019 (accessed 2022)
61 (53 - 70) 2004 Modelled IHME, GBD 2019 (accessed 2022)
63 (55 - 72) 2007 Modelled IHME, GBD 2019 (accessed 2022)
60 (53 - 69) 2005 Modelled IHME, GBD 2019 (accessed 2022)
61 (54 - 70) 2006 Modelled IHME, GBD 2019 (accessed 2022)
65 (56 - 74) 2008 Modelled IHME, GBD 2019 (accessed 2022)
66 (57 - 75) 2009 Modelled IHME, GBD 2019 (accessed 2022)
66 (58 - 76) 2010 Modelled IHME, GBD 2019 (accessed 2022)
67 (58 - 77) 2011 Modelled IHME, GBD 2019 (accessed 2022)
63 (55 - 72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
59 (51 - 68) 2013 Modelled IHME, GBD 2019 (accessed 2022)
52 (45 - 59) 2015 Modelled IHME, GBD 2019 (accessed 2022)
52 (46 - 60) 2016 Modelled IHME, GBD 2019 (accessed 2022)
54 (47 - 61) 2014 Modelled IHME, GBD 2019 (accessed 2022)
52 (45 - 59) 2017 Modelled IHME, GBD 2019 (accessed 2022)
51 (44 - 59) 2018 Modelled IHME, GBD 2019 (accessed 2022)
52 (44 - 59) 2019 Modelled IHME, GBD 2019 (accessed 2022)
52 (44 - 59) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
3 (3 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3 (3 - 4) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 4) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4 (3 - 5) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4 (4 - 5) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 5) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 6) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2008 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 7) 2009 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 8) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 8) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (6 - 9) 2019 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 15) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
96 2019 Survey/reported WHO/UNICEF
97 2020 Survey/reported WHO/UNICEF
96 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
332 2017 Survey/reported EMCDDA, 2019
298 (247 - 350) 2015 Survey/reported EMCDDA, 2017
332 2017 Survey/reported ECDC
332 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.4 (0.30 - 0.50) 2015 Modelled Blach et al, 2017
0.97 (0.78 - 1.19) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.79 - 1.20) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.79 - 1.19) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.77 - 1.16) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.13) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.13) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.75 - 1.13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.12) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.9 (0.73 - 1.10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.71 - 1.08) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.70 - 1.06) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.69 - 1.05) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.04) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.04) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.03) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.03) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.03) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.03) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.03) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.03) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.04) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.68 - 1.04) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.05) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.70 - 1.06) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.88 (0.72 - 1.08) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.73 - 1.11) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.75 - 1.14) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.74 - 1.12) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
49.71 2017 Survey/reported EMCDDA
56.99 2016 Survey/reported EMCDDA
60.16 2015 Survey/reported EMCDDA
62.09 2014 Survey/reported EMCDDA
62.99 2013 Survey/reported EMCDDA
65.81 2012 Survey/reported EMCDDA
65 2011 Survey/reported EMCDDA
69.87 2010 Survey/reported EMCDDA
72.91 2009 Survey/reported EMCDDA
74.05 2008 Survey/reported EMCDDA
76.12 2007 Survey/reported EMCDDA
78.36 2006 Survey/reported EMCDDA
80.55 2005 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.34 (0.25 - 0.40) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.7 (0.60 - 0.90) 2014 Survey/reported Gower et al, 2014
Pregnant women
Download
Value (%) Year Type Source
0.9 (0.50 - 1.50) 2004 Survey/reported Kristiansen MG et al, 2009
People who inject drugs (PWID)
Download
Value (%) Year Type Source
63 (61.80 - 64.20) 2013 Survey/reported EMCDDA
64.8 (60.40 - 69.10) 2012 Modelled Degenhardt L et al, 2017
49.7 2017 Survey/reported EMCDDA
49.71 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of persons living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
21,000 (15,000 - 24,000) 2015 Modelled Blach et al, 2017
37,305 (30,283 - 45,529) 1990 Modelled IHME, GBD 2019 (accessed 2022)
36,511 (29,661 - 44,618) 1991 Modelled IHME, GBD 2019 (accessed 2022)
35,784 (29,046 - 43,801) 1992 Modelled IHME, GBD 2019 (accessed 2022)
35,193 (28,480 - 43,144) 1993 Modelled IHME, GBD 2019 (accessed 2022)
34,806 (28,129 - 42,603) 1994 Modelled IHME, GBD 2019 (accessed 2022)
34,695 (27,974 - 42,395) 1995 Modelled IHME, GBD 2019 (accessed 2022)
34,764 (28,039 - 42,495) 1996 Modelled IHME, GBD 2019 (accessed 2022)
34,868 (28,136 - 42,639) 1997 Modelled IHME, GBD 2019 (accessed 2022)
35,003 (28,259 - 42,826) 1998 Modelled IHME, GBD 2019 (accessed 2022)
35,166 (28,402 - 43,049) 1999 Modelled IHME, GBD 2019 (accessed 2022)
35,359 (28,566 - 43,217) 2000 Modelled IHME, GBD 2019 (accessed 2022)
35,624 (28,798 - 43,528) 2001 Modelled IHME, GBD 2019 (accessed 2022)
35,970 (29,079 - 43,999) 2002 Modelled IHME, GBD 2019 (accessed 2022)
36,375 (29,438 - 44,517) 2003 Modelled IHME, GBD 2019 (accessed 2022)
36,818 (29,840 - 45,054) 2004 Modelled IHME, GBD 2019 (accessed 2022)
37,267 (30,185 - 45,575) 2005 Modelled IHME, GBD 2019 (accessed 2022)
37,975 (30,802 - 46,440) 2006 Modelled IHME, GBD 2019 (accessed 2022)
39,068 (31,729 - 47,798) 2007 Modelled IHME, GBD 2019 (accessed 2022)
40,335 (32,752 - 49,331) 2008 Modelled IHME, GBD 2019 (accessed 2022)
41,548 (33,712 - 50,880) 2009 Modelled IHME, GBD 2019 (accessed 2022)
42,462 (34,414 - 52,048) 2010 Modelled IHME, GBD 2019 (accessed 2022)
43,055 (34,988 - 52,724) 2011 Modelled IHME, GBD 2019 (accessed 2022)
43,537 (35,423 - 53,256) 2012 Modelled IHME, GBD 2019 (accessed 2022)
43,987 (35,733 - 53,855) 2013 Modelled IHME, GBD 2019 (accessed 2022)
44,487 (36,114 - 54,517) 2014 Modelled IHME, GBD 2019 (accessed 2022)
45,126 (36,570 - 55,302) 2015 Modelled IHME, GBD 2019 (accessed 2022)
46,759 (37,966 - 57,255) 2016 Modelled IHME, GBD 2019 (accessed 2022)
48,539 (39,276 - 59,578) 2017 Modelled IHME, GBD 2019 (accessed 2022)
49,165 (39,858 - 60,304) 2018 Modelled IHME, GBD 2019 (accessed 2022)
49,137 (39,834 - 60,263) 2019 Modelled IHME, GBD 2019 (accessed 2022)
48,717 (39,429 - 59,829) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
4,200 (3,000 - 4,900) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
2.97 (2.61 - 3.32) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.46 (2.20 - 2.74) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.43 (2.18 - 2.70) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.45 (2.18 - 2.71) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (2.21 - 2.75) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.23 - 2.78) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.5 (2.24 - 2.79) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.52 (2.25 - 2.80) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (2.26 - 2.82) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.59 (2.32 - 2.88) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (2.34 - 2.91) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (2.33 - 2.89) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (2.33 - 2.91) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.35 - 2.94) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.63 (2.35 - 2.92) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.66 (2.37 - 2.95) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.64 (2.37 - 2.93) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.69 (2.41 - 2.99) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.47 - 3.08) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.81 (2.50 - 3.13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.83 (2.52 - 3.16) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.85 (2.55 - 3.17) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.93 (2.62 - 3.29) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.99 (2.67 - 3.34) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.04 (2.72 - 3.40) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.03 (2.68 - 3.37) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.68 - 3.36) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.05 (2.69 - 3.39) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.01 (2.65 - 3.36) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.62 - 3.32) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.97 (2.61 - 3.32) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
220 2016 Modelled WHO
159 (139 - 177) 2019 Modelled IHME, GBD 2019 (accessed 2022)
159 (139 - 177) 2019 Modelled IHME, GBD 2019 (accessed 2020)
158 (139 - 176) 2018 Modelled IHME, GBD 2019 (accessed 2022)
159 (139 - 177) 2017 Modelled IHME, GBD 2019 (accessed 2022)
159 (140 - 177) 2016 Modelled IHME, GBD 2019 (accessed 2022)
156 (138 - 174) 2015 Modelled IHME, GBD 2019 (accessed 2022)
154 (137 - 172) 2014 Modelled IHME, GBD 2019 (accessed 2022)
154 (137 - 172) 2013 Modelled IHME, GBD 2019 (accessed 2022)
149 (133 - 167) 2012 Modelled IHME, GBD 2019 (accessed 2022)
145 (129 - 162) 2011 Modelled IHME, GBD 2019 (accessed 2022)
138 (124 - 154) 2010 Modelled IHME, GBD 2019 (accessed 2022)
136 (121 - 152) 2009 Modelled IHME, GBD 2019 (accessed 2022)
133 (119 - 149) 2008 Modelled IHME, GBD 2019 (accessed 2022)
130 (116 - 145) 2007 Modelled IHME, GBD 2019 (accessed 2022)
125 (112 - 139) 2006 Modelled IHME, GBD 2019 (accessed 2022)
122 (109 - 135) 2005 Modelled IHME, GBD 2019 (accessed 2022)
122 (109 - 135) 2004 Modelled IHME, GBD 2019 (accessed 2022)
120 (107 - 133) 2003 Modelled IHME, GBD 2019 (accessed 2022)
119 (107 - 133) 2002 Modelled IHME, GBD 2019 (accessed 2022)
118 (105 - 131) 2001 Modelled IHME, GBD 2019 (accessed 2022)
117 (105 - 130) 2000 Modelled IHME, GBD 2019 (accessed 2022)
116 (104 - 129) 1999 Modelled IHME, GBD 2019 (accessed 2022)
115 (103 - 127) 1998 Modelled IHME, GBD 2019 (accessed 2022)
112 (100 - 124) 1997 Modelled IHME, GBD 2019 (accessed 2022)
110 (99 - 123) 1996 Modelled IHME, GBD 2019 (accessed 2022)
109 (97 - 121) 1995 Modelled IHME, GBD 2019 (accessed 2022)
108 (97 - 120) 1994 Modelled IHME, GBD 2019 (accessed 2022)
107 (95 - 119) 1993 Modelled IHME, GBD 2019 (accessed 2022)
105 (94 - 116) 1992 Modelled IHME, GBD 2019 (accessed 2022)
104 (93 - 115) 1991 Modelled IHME, GBD 2019 (accessed 2022)
105 (93 - 116) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
10 (9 - 11) 1990 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 1991 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 11) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11 (10 - 12) 1995 Modelled IHME, GBD 2019 (accessed 2022)
10 (9 - 12) 1993 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
12 (10 - 13) 1997 Modelled IHME, GBD 2019 (accessed 2022)
12 (11 - 13) 1998 Modelled IHME, GBD 2019 (accessed 2022)
13 (11 - 14) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13 (12 - 15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
13 (12 - 14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
14 (12 - 15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
15 (14 - 17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
14 (13 - 16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
16 (14 - 18) 2005 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 18) 2006 Modelled IHME, GBD 2019 (accessed 2022)
18 (16 - 20) 2008 Modelled IHME, GBD 2019 (accessed 2022)
17 (15 - 19) 2007 Modelled IHME, GBD 2019 (accessed 2022)
19 (17 - 21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
20 (17 - 22) 2010 Modelled IHME, GBD 2019 (accessed 2022)
20 (18 - 23) 2011 Modelled IHME, GBD 2019 (accessed 2022)
22 (19 - 24) 2012 Modelled IHME, GBD 2019 (accessed 2022)
22 (20 - 25) 2013 Modelled IHME, GBD 2019 (accessed 2022)
23 (20 - 26) 2014 Modelled IHME, GBD 2019 (accessed 2022)
24 (21 - 27) 2015 Modelled IHME, GBD 2019 (accessed 2022)
24 (21 - 27) 2016 Modelled IHME, GBD 2019 (accessed 2022)
25 (21 - 28) 2017 Modelled IHME, GBD 2019 (accessed 2022)
24 (21 - 27) 2018 Modelled IHME, GBD 2019 (accessed 2022)
24 (20 - 27) 2019 Modelled IHME, GBD 2019 (accessed 2022)
42 (38 - 47) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
332 2017 Survey/reported EMCDDA, 2019
298 (247 - 350) 2015 Survey/reported EMCDDA, 2017
332 2017 Survey/reported ECDC
332 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Some (11-30%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.56 (%)
2019
(0.48 - 0.64(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
0.91 (%)
2019
(0.74 - 1.12(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV (anti-HCV)
0.7 (%)
2014
(0.6 - 0.9(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
52
2019
(44 - 59)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
159
2019
(139 - 177)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.02 (%)
2020, latest modelled
(0.01 - 0.03(%))
WHO

Prevalence PWID

HCV
49.70 (%)
2017, survey/surveillance
EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
332
2017
ECDC
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs